Another noteworthy translocation, t(14;16)(q32;q23), occurs in 5–10% of cases and drives c-MAF overexpression, which in turn activates cyclin D2, integrin β, and chemokine receptor type 1 (CCR1), collectively promoting MM cell proliferation [52,53]. The gene discussed is MAF; the disease is Miyoshi myopathy.